Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

OptimizeRx (OPRX) Non-cash Items (2018 - 2024)

OptimizeRx's Non-cash Items history spans 7 years, with the latest figure at $3.7 million for Q4 2024.

  • For Q4 2024, Non-cash Items rose 249.04% year-over-year to $3.7 million; the TTM value through Dec 2024 reached $3.7 million, up 249.04%, while the annual FY2024 figure was $3.7 million, 249.04% up from the prior year.
  • Non-cash Items for Q4 2024 was $3.7 million at OptimizeRx, down from $4.1 million in the prior quarter.
  • Across five years, Non-cash Items topped out at $4.1 million in Q3 2024 and bottomed at $26410.0 in Q1 2021.
  • The 5-year median for Non-cash Items is $1.1 million (2020), against an average of $1.5 million.
  • The largest annual shift saw Non-cash Items plummeted 96.71% in 2020 before it surged 249.04% in 2024.
  • A 5-year view of Non-cash Items shows it stood at $1.2 million in 2020, then tumbled by 93.55% to $78334.0 in 2021, then soared by 1863.07% to $1.5 million in 2022, then tumbled by 31.98% to $1.0 million in 2023, then soared by 249.04% to $3.7 million in 2024.
  • Per Business Quant, the three most recent readings for OPRX's Non-cash Items are $3.7 million (Q4 2024), $4.1 million (Q3 2024), and $492000.0 (Q1 2024).